Rise & Shine: What you need to know before the ASX opens

On Stockhead today, renowned investor Tolga Kumova’s exclusive insights into which ASX stocks could be potential life-changers in 2021, the ASX stocks working for Wilson Asset Management, and heavy earths are already moving as the EV sector lifts.

But first…
 

The day ahead

Investors will be wanting to hear the details of President-Elect Joe Biden’s proposed ‘economic rescue package’ for the American economy.

The package is set to be delivered to the US Congress on Thursday evening, US time, and there is speculation the amount involved could add up to $US2 trillion ($2.5 trillion).

Bond yields, the effective rate of interest, on 10-year US Treasuries went up to 1.1 per cent ahead of Biden’s speech, and were trading at 0.9 per cent last week.

Higher bond rates could start to impact prices for alternative assets such as gold or cryptocurrencies which have already been unsettled this week.

TRADING HALTS

The following companies are in trading halts and are expected to exit over the next two trading days:

Friday: 

Sagalio Energy (ASX:SAN) – price query
Prominence Energy (ASX:PRM) – capital raising
Global Oil & Gas (ASX:GLV) – capital raising
Whitebark Energy (ASX:WBE) – investment outcome
DiscovEx Resources (ASX:DCX) – capital raising & acquisition
Galileo Mining (ASX:GAL) – price query

Monday:

Shekel Brainweigh (ASX:SBW) – capital raising

MARKETS

Gold: $US1,855.01 ($2,387.40) (+0.56%)

Silver: $US25.60 ($32.95) (+2.70%)

Oil (WTI): $US53.14 (+1.70%)

Oil (Brent): $US56.53 (+1.56%)

Coal: $US85.00 (+0.00%)

Iron 62pc Fe: $US169.33 (+0.20%)

AUD/USD: $US0.7772 (+0.97%)

Bitcoin: $US34,304.29 (+9.00%)

What got you talking yesterday

Readers were discussing Strike Energy’s (ASX:STX) production suspension of its West Erregulla-3 gas well in the Perth Basin and its implications for the company, and they liked another gas story, this time on the boost to revenue for Australian gas companies from 11-year high LNG prices.

Monday’s upcoming float of CAR T cell therapy company Chimeric Therapeutics (ASX:CHM) after its $35m IPO is keenly awaited by ASX investors.

To keep up to date with Stockhead coverage, follow our Twitter page or sign up to our members-only Facebook group here.

Also, be sure to check in at 10.20am each day for our daily 10 at 10 column — a live summary of winners & losers at the opening bell.

Yesterday’s winners

Stocks highlighted in yellow made market moving announcements

Yesterday’s losers